Lithium-induced neuroleptic malignant syndrome: A case report

Hong Kong Journal of Psychiatry

Volumn 17, Issue 3, 2007, Pages 101-102

  Rai, Sachin ^a   Arun, Priti ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Lithium toxicity; Neuroleptic malignant syndrome; Risk factors

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LITHIUM; OLANZAPINE; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG BLOOD LEVEL; HUMAN; LABORATORY TEST; MALE; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; RISK FACTOR; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT INDICATION;

EID: 36049046782     PISSN: 10262121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv 1998;49:1163-72.
2. Lazarus A, Mann SC, Caroff SN. The neuroleptic malignant syndrome and related conditions. Washington DC: American Psychiatric Press; 1989.
3. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry 1987;22:1004-20.
4. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41:79-82.
5. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-45.
6. Friedman LS, Weinrauch LA, D'Elia JA. Metoclopramide-induced neuroleptic malignant syndrome. Arch Intern Med 1987;147:1495-7.
7. Keck PE, Pope HG, Cohen BM, McElory SL, Nierenberg AA. Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry 1989;46:914-8.
8. Berardi D, Amore M, Keck PE, Troia M, Dell'Atti M. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Biol Psychiatry 1998;44:748-54.
9. Gibb WR, Wedzicha JA, Hoffbrand BI. Recurrent neuroleptic malignant syndrome and hyponatraemia. J Neurol Neurosurg Psychiatry 1986;49:960-1.
10. Joseph JK, Thomas K. Lithium toxicity - a risk factor for neuroleptic malignant syndrome. J Assoc Physicians India 1991;39:572-3.
11. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 2004;101:5099-104.